XLock Biosciences is a pre-clinical stage biotechnology company overcoming the challenges of chemokine-targeted drug development with protein engineering.
XLock BiosciencesA fundamental property of the human body is the movement of cells within and between tissues. Cell movement, also known as cell migration, has beneficial effects, for example wound healing or leukocyte trafficking in infection. Cell migration, however, may have deleterious effects, such as the invasion and metastasis of tumor cells or chronic inflammation. Immune molecules known as chemokines are the prototypical regulator of cell migration. XLock Biosciences is seeking to improve human health through the design of new chemokine-targeted therapies or treatment strategies to inhibit deleterious cell migration in cancer and inflammation.
|
POTENTIAL ADVANTAGES OF
XLOCK BIOSCIENCES’ CHEMOKINE BASED THERAPIES
Greater Selectivity |
Avoidance of general immune system suppression |
Does not promote production of anti-drug antibodies |
VIRTUALLY COMPLETE CLEARANCE OF DISEASE SYMPTOMS |